Skip to main content
. 2014 Jan 10;4(1):e173. doi: 10.1038/bcj.2013.71

Figure 3.

Figure 3

Analysis of 36 diagnostic and 36 follow-up samples. (a) Nine NPM1mut patients with low BAALC expression at diagnosis, (b) 13 patients with NPM1mut and high BAALC expression levels at diagnosis. Figures (a) and (b) represent BAALC expression levels at diagnosis and at first CMR defined by undetectable NPM1mut. (c) Fourteen patients with high BAALC expression at diagnosis and samples of first relapse available. P-values were derived by paired Student's t-test. The dashed line represents the median BAALC expression level (33.1% BAALC/ABL1) of the diagnostic cohort.